Billiontoone, Inc. (NASDAQ:BLLN) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Billiontoone, Inc. (NASDAQ:BLLN) have received an average recommendation of “Moderate Buy” from the ten research firms that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $126.7143.

A number of brokerages recently issued reports on BLLN. Wall Street Zen downgraded Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday. BTIG Research lowered their target price on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research note on Thursday. Weiss Ratings upgraded shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. Guggenheim began coverage on shares of Billiontoone in a research note on Monday, June 29th. They issued a “buy” rating and a $125.00 price target on the stock. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a report on Thursday.

Insider Transactions at Billiontoone

In other news, insider Shan Riku Sakakibara sold 4,000 shares of Billiontoone stock in a transaction on Friday, July 31st. The stock was sold at an average price of $140.21, for a total value of $560,840.00. Following the completion of the sale, the insider directly owned 200,000 shares of the company’s stock, valued at approximately $28,042,000. The trade was a 1.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock in a transaction on Monday, June 29th. The shares were sold at an average price of $120.00, for a total value of $169,920.00. Following the completion of the sale, the senior vice president directly owned 33,552 shares of the company’s stock, valued at $4,026,240. The trade was a 4.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 202,049 shares of company stock worth $23,496,861 in the last ninety days. 50.22% of the stock is owned by company insiders.

Hedge Funds Weigh In On Billiontoone

Several institutional investors have recently bought and sold shares of the company. Adams Street Partners LLC acquired a new stake in shares of Billiontoone during the fourth quarter worth about $140,063,000. Baillie Gifford & Co. purchased a new position in shares of Billiontoone in the fourth quarter valued at approximately $103,786,000. Price T Rowe Associates Inc. MD acquired a new position in shares of Billiontoone in the fourth quarter valued at approximately $39,717,000. JPMorgan Chase & Co. purchased a new stake in Billiontoone during the 4th quarter worth approximately $32,078,000. Finally, Wasatch Advisors LP purchased a new stake in Billiontoone during the 1st quarter worth approximately $29,179,000.

Billiontoone Price Performance

BLLN stock opened at $93.39 on Friday. Billiontoone has a 52-week low of $61.96 and a 52-week high of $150.44. The company has a quick ratio of 10.58, a current ratio of 11.69 and a debt-to-equity ratio of 0.17. The stock has a market cap of $4.30 billion and a price-to-earnings ratio of 133.41. The business has a fifty day moving average of $116.49 and a two-hundred day moving average of $94.28.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 EPS for the quarter, meeting the consensus estimate of $0.15. The business had revenue of $109.45 million for the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. As a group, research analysts anticipate that Billiontoone will post 0.92 earnings per share for the current year.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.